(Q82600359)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19007975%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

PTEN promoter methylation and LOH of 10q22-23 locus in PTEN expression of ovarian clear cell adenocarcinomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19007975%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Chih-Ming Ho

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19007975%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ming-Chieh Lin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19007975%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Shih-Hung Huang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19007975%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Chi-Jung Huang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19007975%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Hung-Cheng Lai

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19007975%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Tsai-Yen Chien

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19007975%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Shwu-Fen Chang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19007975%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

12 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19007975%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19007975%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19007975%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19007975%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

307-313

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19007975%20AND%20SRC:MED&resulttype=core&format=json

Ovarian clear cell adenocarcinoma

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

The multiple roles of PTEN in tumor suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Reduced PTEN expression in gastric cancer and in the gastric mucosa of gastric cancer relatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Loss of tumor suppressor protein PTEN during renal carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

PTEN expression in clear cell adenocarcinoma of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Analysis of PTEN and the 10q23 region in primary prostate carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Pten, a protean tumor suppressor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Cancer epigenetics comes of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Hypermethylation of the PTEN gene in ovarian cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Tumour suppressor gene expression correlates with gastric cancer prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Loss of PTEN expression followed by Akt phosphorylation is a poor prognostic factor for patients with endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Time to progression is dependent on the expression of the tumour suppressor PTEN in ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.040

10.1016/J.YGYNO.2008.09.040

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19007975%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference